Ta‐Ching Chen
Papers
1
Total Citations
2
H-Index
1
About
Ta-Ching Chen is a leading ophthalmologist and researcher whose work sits at the critical intersection of vitreoretinal surgery and biomedical engineering. His primary research areas focus on optimizing surgical techniques for gene therapy delivery, particularly through the refinement of subretinal injection (SRI) procedures. Chen’s major contribution lies in his systematic analysis of the key parameters governing bleb formation during SRI—a crucial step for ensuring the safety and efficacy of emerging gene therapies for retinal diseases. By identifying and quantifying these variables, his work provides a foundational framework for developing predictable, robot-assisted treatments that can standardize this delicate procedure. While his most-cited paper from 2023 has garnered 2 citations, its significance is amplified by its forward-looking impact on the automation of ophthalmic surgery. Chen’s research is not merely academic; it directly addresses a pressing clinical need for more reliable and reproducible methods in the rapidly evolving field of retinal gene therapy, positioning him as a key figure in translating engineering precision into tangible patient benefits.
Research Focus
Key Achievements
Top Papers
- 1